This meta-analysis looked at 1,055 patients with trigeminal neuralgia who underwent stereotactic radiosurgery (SRS). The study compared two different ways of targeting the area: distal targeting and proximal targeting. The goal was to see which method provided better pain relief and fewer side effects.
Researchers found that patients who received distal targeting reported significantly higher pain relief at the 30-day mark compared to those with proximal targeting. However, by the 90-day mark, there was no significant difference in pain relief between the two methods. Other outcomes, such as complete pain freedom, facial numbness, and the ability to reduce medication, were similar for both groups.
Because the study included retrospective data, the results show a link rather than a direct cause. While distal targeting may be helpful for patients needing quick relief, both methods showed similar long-term results and safety profiles. Patients should talk to their doctors to decide which approach fits their specific needs.
